AI assistant
REPLIGEN CORP — Director's Dealing 2025
Mar 20, 2025
30826_dirs_2025-03-20_8f1032f6-738b-4376-95b9-d08c72e9b812.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2025-03-13
Reporting Person: Bylund James (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-13 | Common Stock | A | 381 | — | Acquired | 24340 | Direct |
| 2025-03-13 | Common Stock | F | 175 | $142.44 | Disposed | 24165 | Direct |
Footnotes
F1: Represents 63 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on May 16, 2023, and 318 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on December 12, 2023. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.
F2: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of the performance stock units.